Fed­er­al judge up­holds Cabome­tyx patent in Ex­elix­is' gener­ic bat­tle

A fed­er­al judge up­held a key patent on Ex­elix­is’ can­cer drug Cabome­tyx on Thurs­day, deal­ing a blow to MSN Lab­o­ra­to­ries’ po­ten­tial gener­ic ver­sion.

Ex­elix­is filed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER